🇺🇸 FDA
Patent

US 8349892

Solid formulations of prostacyclin analogs

granted A61KA61K31/215A61P

Quick answer

US patent 8349892 (Solid formulations of prostacyclin analogs) held by United Therapeutics Corporation expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/215, A61P, A61P17/06, A61P9/04